Topical treatment of cutaneous leishmaniasis with lipozomal azithromyci
Phase 2
- Conditions
- Cutaneous Leishmaniasis.Cutaneous Leishmaniasis
- Registration Number
- IRCT2014031216955N1
- Lead Sponsor
- Mashhad University of Medical Sciences, Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Presence of cutaneous leishmaniasis with less than 12 weeks of clinical course; Not receive any treatment before
Exclusion criteria: Pregnancy; Lactating; Receiving simultanous treatment with other methods during treatment course; Sensitivity or intolerance to Macrolids;
History of significance renal; Pulmonary and cardiovascular disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method esion improvement. Timepoint: Weekly until 6 weeks. Method of measurement: Measuring the size of induration and ulcer by caliper.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Weekly. Method of measurement: Clinical evaluation.